THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. (TSOI)
Clinical trial NCT06545929 updates: 1. collaborators added: Imbrium Therapeutics 2. collaborators removed: Purdue Pharma LP
Clinical trial NCT06545929 updates: 1. collaborators added: Imbrium Therapeutics 2. collaborators removed: Purdue Pharma LP
📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak clinical signals • Minimal impact anticipated **Sentiment:** Neutral (50%) **Content type:** Clinical